KURA:NASDAQ, Kura Oncology, Inc.
KURA stock overview
Kura Oncology, Inc. (KURA:NASDAQ) closed at $9.08 on October 16, 2026,
down 6.39% on the day.
The stock trades 34.7% below its 52-week high of $13.90
and 23.4% above its 52-week low of $7.36.
Over the past year, it lost 7.7%.
Kura Oncology, Inc. is part of the Health Care sector (Major Pharmaceuticals).
Key figures
- Price
- $9.08
- Day change
- -6.39%
- Volume
- 1,780,627
- Average volume
- 1,807,554
- Market cap
- 807M+
- 52-week range
- $7.36 – $13.90
- 50-day average
- $11.32
- 200-day average
- $9.80
Performance
| 5D |
1M |
3M |
6M |
1Y |
| -12.65% |
-22.53% |
-14.98% |
-7.16% |
-7.72% |
Price action over the past year
In 252 trading sessions since October 16, 2025, KURA closed higher on 118 days (47%).
Its best day was May 20, 2026 (+15.40%) and its worst was June 1, 2026 (-11.42%).
The stock moved 10% or more in a single session 4 times.
It opened at least 5% above the previous day's high 3 times.
Recent signals
KURA news
-
Oct 14, 2026:
Kura Oncology Launches $50M-Backed Diabetes Venture for Oral Menin Inhibitor
-
Oct 13, 2026:
Caspian Therapeutics and Kura Oncology Outline KO-7246 Development Strategy in Diabetes
-
Oct 7, 2026:
Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian's Launch and KO-7246 Preclinical Data in Diabetes
-
Oct 2, 2026:
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Oct 1, 2026:
Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors
-
Sep 29, 2026:
Caspian Therapeutics and Kura Oncology Report Preclinical Data for Diabetes Candidate KO-7246
-
Sep 29, 2026:
Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes
-
Sep 9, 2026:
Kura Oncology Pivots Diabetes Strategy Into $50 Million Subsidiary
About Kura Oncology, Inc.
Kura Oncology Inc is a clinical stage biopharmaceutical company, engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers.
Similar stocks
Find more stocks like KURA with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.